Midazolam deaths

Excess Deaths in the United Kingdom: Midazolam and Euthanasia in the COVID-19 Pandemic

Citation: Wilson Sy (2024) Excess Deaths in the United Kingdom: Midazolam and Euthanasia in the COVID-19 Pandemic. Medical & Clinical Research, 9(2), 01-21.

Macro-data during the COVID-19 pandemic in the United Kingdom (UK) are shown to have significant data anomalies and inconsistencies with existing explanations.

England 2020

UK spike in deaths,

wrongly attributed to COVID-19 in April 2020,

was not due to SARS-CoV-2 virus,

which was largely absent,

but was due to the widespread use of Midazolam injections,

which were statistically very highly correlated (coefficient over 90 percent) with excess deaths in all regions of England during 2020.

Importantly

Excess deaths remained elevated following mass vaccination in 2021,

but were statistically uncorrelated to COVID injections,

while remaining significantly correlated to Midazolam injections.

The widespread and persistent use of Midazolam in UK suggests a possible policy of systemic euthanasia.

Unlike Australia, where assessing the statistical impact of COVID injections on excess deaths is relatively straightforward,

UK excess deaths were closely associated with the use of Midazolam and other medical intervention.

The UK iatrogenic pandemic

Caused by euthanasia deaths from Midazolam and also,

likely caused by COVID injections,

but their relative impacts are difficult to measure from the data, due to causal proximity of euthanasia.

Global investigations of COVID-19 epidemiology,

based only on the relative impacts of COVID disease and vaccination,

may be inaccurate, due to the neglect of significant confounding factors in some countries.